<p class="First-paragraph-drop-cap">The Food and Drug Administration’s vaccine advisory committee has approved the use of the COVID-19 vaccine developed by Pfizer Inc. (NYC) and BioNTech (Mainz, DEU) in the United States for those ages 16 years and older. The first doses will go to healthcare workers and long-term care residents.</p>

FDA Approves Pfizer Vaccine for COVID-19

Name: Relias Media
Price range: $

Designated groups first, but approval is for all 16 years of age and older

January 1, 2021

The Food and Drug Administration’s vaccine advisory committee has approved the use of the COVID-19 vaccine developed by Pfizer Inc. (NYC) and BioNTech (Mainz, DEU) in the United States for those ages 16 years and older. The first doses will go to healthcare workers and long-term care residents.

Issue Date: January 1, 2021

Table of Contents

Financial Disclosure: Peer Reviewer Patrick Joseph, MD, reports that he is a consultant for Genomic Health, Siemens, and CareDx. Senior Writer Gary Evans, Author Philip R. Fischer, MD, DTM&H, Editor Jason Schneider, Associate Editor Mike Gates, Nurse Planner Patti Grant, RN, BSN, MS, CIC, and Editorial Group Manager Leslie Coplin report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

FDA Approves Pfizer Vaccine for COVID-19

Designated groups first, but approval is for all 16 years of age and older

Subscribe Now for Access